A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine
Email
Print
Playlists: triple negative breast cancer sara chumsri research progesterone her2 estrogen dr sara chumsri cancer research breast cancer treatment breast cancer
Triple negative breast cancer is an aggressive sub-type of breast cancer in which the tumor cells lack all of the conventional drug targets for breast cancer, such as estrogen, progesterone and HER2 receptors. Because the tumor cells lack these receptors, treatments such as hormone therapy, like tamoxifen and aromatase inhibitors, or drugs that target HER2, like Herceptin, are not effective.
In this video, Dr. Sara Chumsri, a member of the UMGCC Breast Evaluation and Treatment Program, discusses triple negative breast cancer and some of the promising new research underway to develop new therapies to successfully treat this type of breast cancer.
Click to Print
Print Preview
